Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 751-757

  Andreassen, Ole A ^a   Aamo, Trond O ^b   Jørgensen, Hugo A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Glutamate; Memantine (1 amino 3,5 dimethyladamantane); Motor activity; Neuroleptics; NMDA antagonist; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

GLUTAMATE RECEPTOR; HALOPERIDOL; HALOPERIDOL DECANOATE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SESAME SEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MASTICATION; MOTOR ACTIVITY; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; TARDIVE DYSKINESIA; VIDEOTAPE;

EID: 0029998027     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15736.x     Document Type: Article

References (48)

1. AHLENIUS, S. & HILLEGAART, V. (1986). Involvement of extra-pyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission. Pharmacol. Biochem. Behav., 24, 1409-1415.
2. AMERICAN PSYCHIATRIC ASSOCIATION. (1992). Tardive dyskinesia: a Task Force Report of the American Psychiatric Association. Washington DC: APA.
3. ANDREASSEN, O.A. & JØRGENSEN, H.A. (1994). GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats. Psychopharmacology, 116, 517-522.
4. ANDREASSEN, O.A. & JØRGENSEN, H.A. (1995a). The mitochondrial toxin 3-nitropropionic acid induces vacuous chewing movements in rats. Implications for tardive dyskinesia? Psychopharmacology, 119, 474-476.
5. ANDREASSEN, O.A. & JØRGENSEN, H.A. (1995b). The rat model of tardive dyskinesia: Relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment. Life Sci., 57, 2263-2272.
6. BARNES, C.A., DANYSZ, W. & PARSONS, C.G. (1996). Effects of uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake freely moving rats. Eur. J. Neurosci., 8, 565-571.
7. BEAL, M.F., HYMAN, B.T. & KOROSHETZ, W. (1993). Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci., 16, 125-131.
8. BORMANN, J (1989). Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol., 166, 591-592.
9. BUBSER, M., KESEBERG, U., NOTZ, P.K. & SCHMIDT, W.J. (1992). Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists. Eur. J. Pharmacol., 229, 75-82.
10. BURCKHARDT, C., KELLY, J.P., LIM, Y.H., FILLEY, C.M. & PARKER, W.D.JR (1993). Neuroleptic medications inhibit complex I of the electron transport chain. Ann. Neurol., 33, 512-517.
11. BYCZKOWSKI, J.Z. & BORYSEWICZ, R. (1979). The action of chlorpromazine and imipramine on rat brain mitochondria. Gen. Pharmacol., 10, 369-372.
12. CHEN, H.S.V., PELLEGRINI, J.W., AGGARWAL, S.K., LEI, S.Z., WARACH, S., JENSEN, F.E. & LIPTON, S.A. (1992). Open channel block of N-Methyl-D-Aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci., 12, 4427-4436.
13. DANYSZ, W., ESSMANN, U., BRESINK, I. & WILKE, R. (1994). Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav., 48, 111-118.
14. DEKEYSER, J. (1991). Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia. Clin. Neuropharmacol., 14, 562-565.
15. EGAN, M.F., HURD, Y., HYDE, T.M., WEINBERGER, D.R., WYATT, R.J. & KLEINMAN, J.E. (1994). Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse, 18, 178-189.
16. FAVARON, M., MANEV, H., ALHO, H., BERTOLINO, M., FERRET, B., GUIDOTTI, A. & COSTA, E. (1988). Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc. Natl. Acad. Sci. U.S.A., 85, 7351-7355.
17. GALLAGHER, C.H., KOCH, J.H. & MANN, D.M. (1965). The effect of phenothiazine on the metabolism of liver mitochondria. Biochem. Pharmacol., 14, 789-797.
18. GOFF, D.C., TSAI G., BEAL, M.F. & COYLE, J.T. (1995). Tardive dyskinesia and substrates of energy metabolism. Am. J. Psychiatry, 152, 1730-1736.
19. GUNNE, L.M., ANDERSSON, U., BONDESSON, U. & JOHANSSON, P. (1986). Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav., 25, 897-901.
20. IMPERATO, A. & DI CHIARA, G. (1985). Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J. Neurosci., 5, 297-306.
21. JESTE, D.V. & CALIGIURI, M.P. (1993). Tardive dyskinesia. Schizophr. Bull., 19, 303-315.
22. JESTE, D.V., LOHR, J.B. & MANLEY, M. (1992). Study of neuropathological changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology, 106, 154-160.
23. KANE, J.M. (1992). Tardive dyskinesia. In Movement Disorders in Neurology and Neuropsychiatry, ed. Joseph, A.B. & Young, R.R. pp. 33-39. Oxford: Blackwell.
24. KORNHUBER, J., WELLER, M., SCHOPPMEYER, K. & RIEDERER, P. (1994). Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J. Neural Transm., (Suppl), 43, 91-104.
25. LEVIN, E.D., SEE, R.E. & SOUTH, D (1989). Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats. Pharmacol. Biochem. Behav., 34, 43-48.
26. LIPTON, S.A. (1993). Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide. Trends. Neurosci., 16, 527-532.
27. MANEV, H., COSTA, E., WROBLEWSKI, J.T. & GUIDOTTI, A. (1990). Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity. FASEB J., 4, 2789-2797.
28. MARCO, L.A. & JOSHI, R.S. (1992). A ketamine-induced rat model of tardive dyskinesia. Prog. Neurobiol., 38, 571-600.
29. MCGEER, E.G. & MCGEER, P.L. (1976). Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature, 263, 517-519.
30. MESHUL, C.K., STALLBAUMER, R.K., TAYLOR, B. & JANOWSKY, A. (1994). Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res., 648, 181-195.
31. MILLER, R. & CHOUINARD, G. (1993). Loss of striatal cholinergic neurons as a basis for tardive dyskinesia and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biol. Psychiatry, 34, 713-738.
32. MISTRY, R., WILKE, R. & CHALLISS, R.A.J. (1995). Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex. Br. J. Pharmacol., 114, 797-804.
33. MISZTAL, M., FRANKIEWICZ, T., PARSONS, C.G. & DANYSZ, W. (1996). Learning deficits induced by chronic intraventricular infusion of quinolinic acid - protection by MK-801 and memantine. Eur. J. Pharmacol., 296, 1-8.
34. MOGHADDAM, B. & BUNNEY, B.S. (1993). Depolarization inactivation of dopamine neurons: terminal release characteristics. Synapse, 14, 195-200.
35. OSSOWSKA, K. (1994). The role of excitatory amino acids in experimental models of Parkinson's disease. J. Neural Transm., (P-D Sect) 8, 39-71.
36. PARSONS, C.G., GRUNER, R., ROZENTAL, J., MILLAR, J. & LODGE, D. (1993). Patch clamp studies of the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology, 32, 1337-1350.
37. PISA, M. & BOSILJEVAC, D. (1994). Heterogeneous motor roles of glutamate receptor subtypes in the rat's striatum. Soc. Neurosci. Abstr., 20, 1.
38. ROGAWSKI, M.A. (1993). Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends. Pharmacol. Sci., 14, 325-331.
39. ROSENGARTEN, H., SCHWEITZER, J.W. & FRIEDHOFF, A.J. (1983). Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci, 33, 2479-2482.
40. SCHNEIDER, E., FISCHER, P.A., CLEMENS, R., BALZEREIT, F., FÜNFGELD, E.W. & HAASE, H.J. (1984). Effects of oral memantine on symptoms of Parkinson's disease. Deutsche Med. Wochenzeitschr., 109, 987-990.
41. SHIGENAGA, M.K., HAGEN, T.M. & AMES, B.N. (1994). Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. U.S.A., 91, 10771-10778.
42. SPANAGEL, R., EILBACHER, B. & WILKE, R. (1994). Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur. J. Pharmacol., 262, 21-26.
43. WADDINGTON, J.L. (1989). Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: The enigma of tardive dyskinesia, its neurobiological determinants, and the conflicts of paradigms. Int. Rev. Neurobiol., 31, 297-353.
44. WADDINGTON, J.L., CROSS, A.J., GAMBLE, S.J. & BOURNE, R.C. (1983). Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science, 220, 530-532.
45. WESEMAN, W., SONTAG, K.H. & MAJ, J. (1983). On the pharmaco-dynamics and pharmacokinetics of memantine. Arzneim Forsch./ Drug Res., 33, 1122-1134.
46. WESTERINK, B.H.C. & DE VRIES, J.B. (1989). On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci. Lett., 99, 197-202.
47. WILLETS, J., BALSTER, R.L. & LEANDER, J.D. (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci., 11,423-428.
48. YAMAMOTO, B.K. & COOPERMAN, M.A. (1994). Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci., 14, 4159-4166.